← All companies

PYXS

Pyxis Oncology, Inc.

PYXS Nasdaq Pharmaceutical Preparations EDGAR ↗

$3.04

+0.39 +14.72%

Key statistics

from XBRL data in SEC filings

Market cap

$193M

Revenue (TTM)

$13.9M

Net income (TTM)

-$81.7M

EPS (TTM)

$-1.30

P/E ratio

—

Dividend yield

—

Free cash flow

-$63.5M

Cash

$5.77M

Total assets

$64.3M

Gross margin

—

52-week range

$0.97 – $5.55

Recent SEC filings

40 most recent

Annual, quarterly & current reports

8-K Entered a material agreement; Unregistered sale of equity; Regulation FD disclosure Jul 2, 2026 8-K Shareholder vote results Jun 15, 2026 10-Q Quarter ended 2026-03-31 May 14, 2026 8-K Results of operations (earnings release) May 14, 2026 8-K/A Director or officer change Apr 30, 2026 10-K Fiscal year ended 2025-12-31 Mar 23, 2026 8-K Results of operations (earnings release); Regulation FD disclosure Mar 23, 2026 8-K Feb 6, 2026 8-K Regulation FD disclosure; Other events Dec 18, 2025 10-Q Quarter ended 2025-09-30 Nov 3, 2025 8-K Results of operations (earnings release) Nov 3, 2025 10-Q Quarter ended 2025-06-30 Aug 14, 2025 8-K Results of operations (earnings release) Aug 14, 2025 8-K Other events Aug 4, 2025 8-K Director or officer change Jul 3, 2025 8-K Shareholder vote results Jun 18, 2025 10-Q Quarter ended 2025-03-31 May 15, 2025 8-K Results of operations (earnings release); Regulation FD disclosure May 15, 2025 8-K Regulation FD disclosure Mar 24, 2025 10-K Fiscal year ended 2024-12-31 Mar 18, 2025 8-K Results of operations (earnings release); Director or officer change; Regulation FD disclosure Mar 18, 2025 8-K Other events Feb 26, 2025 8-K Other events Feb 4, 2025 8-K Other events Dec 19, 2024 8-K Regulation FD disclosure Nov 20, 2024 10-Q Quarter ended 2024-09-30 Nov 12, 2024 8-K Results of operations (earnings release) Nov 12, 2024 8-K Shareholder vote results Oct 23, 2024 10-Q Quarter ended 2024-06-30 Aug 14, 2024 8-K Results of operations (earnings release) Aug 14, 2024 8-K Shareholder vote results Jun 12, 2024 8-K Director or officer change; Regulation FD disclosure Jun 10, 2024 10-Q Quarter ended 2024-03-31 May 14, 2024 8-K Results of operations (earnings release) May 14, 2024 8-K Other events Mar 27, 2024 8-K Other events Mar 27, 2024 10-K Fiscal year ended 2023-12-31 Mar 21, 2024 8-K Results of operations (earnings release); Regulation FD disclosure Mar 21, 2024 8-K Director or officer change; Regulation FD disclosure Mar 13, 2024 8-K Entered a material agreement; Unregistered sale of equity; Regulation FD disclosure Feb 28, 2024